13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q4 2023 · Filed October 18, 2023 · Accession 0000950123-23-008852
Total Value
$313.2M
Positions
6
Other Managers
1
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $129.2M | 41.24% |
| 2 | VAXCYTE INC | PCVX | 1,049,893 | $53.5M | 17.09% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 3,760,869 | $39.0M | 12.45% |
| 4 | MERUS N V | N5749R100 | 1,600,000 | $37.7M | 12.05% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $27.3M | 8.71% |
| 6 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $26.5M | 8.47% |